EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma

Fei Xie, Jinrong Qiu, Congyong Sun, Lulu Feng, Yali Jun, Chao Luo, Xiamei Guo, Bowei Zhang, Yu Zhou, Yuting Wang, Li Zhang, Qilong Wang iD

Advanced Science · 2024-07 · 11 (28)

DOI: 10.1002/advs.202309084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.05.2024. Verfasst von Fei Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Comprehensive Cancer Center, Department of Central Laboratory, The Affiliated Huaian No.1 People's Hospital, Nanjing Medical University, Huai'an,…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Aptamers, Nucleotide, Esophageal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Provincial Medical Key Discipline Cultivation Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is a prevalent gastrointestinal cancer characterized by high mortality and an unfavorable prognosis. While combination therapies involving surgery, chemotherapy, and radiation therapy are advancing, targeted therapy for ESCC remains underdeveloped. As a result, the overall five‐year survival rate for ESCC is still below 20%. Herein, ESCC‐specific DNA aptamers and an innovative aptamer‐modified nano‐system is introduced for targeted drug and gene delivery to effectively inhibit ESCC. The EA1 ssDNA aptamer, which binds robustly to ESCC cells with high specificity and affinity, is identified using cell‐based systematic evolution of ligands by exponential enrichment (cell‐SELEX). An EA1‐modified nano‐system is developed using a natural egg yolk lipid nanovector (EA1‐EYLNs‐PTX/siEFNA1) that concurrently loads paclitaxel (PTX) and a small interfering RNA of Ephrin A1 (EFNA1). This combination counters ESCC's proliferation, migration, invasion, and lung metastasis. Notably, EFNA1 is overexpressed in ESCC tumors with lung metastasis and has an inverse correlation with ESCC patient prognosis. The EA1‐EYLNs‐PTX/siEFNA1 nano‐system offers effective drug delivery and tumor targeting, resulting in significantly improved therapeutic efficacy against ESCC tumors. These insights suggest that aptamer‐modified nano‐systems can deliver drugs and genes with superior tumor‐targeting, potentially revolutionizing targeted therapy in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaAptamers, NucleotideEsophageal NeoplasmsHumansAnimalsMicePaclitaxelCell Line, TumorDisease Models, AnimalDrug Delivery SystemsCell ProliferationSELEX Aptamer Technique

Stichwörter der Autor:innen

DNA aptamersdrug deliveryesophageal squamous cell carcinomanano‐systemstumor targeting

Substanzen

Aptamers, NucleotidePaclitaxel

Autor:innen und Institutionen

  • The Comprehensive Cancer Center, Department of Central Laboratory, The Affiliated Huaian No.1 People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
  • The Comprehensive Cancer Center, Department of Clinical Oncology, The Affiliated Huaian No.1 People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, 223300, China.

ORCID-Profile: Qilong Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Provincial Medical Key Discipline Cultivation Unit

Zitieren

APA

Xie, F., Qiu, J., Sun, C., Feng, L., Jun, Y., Luo, C., Guo, X., Zhang, B., Zhou, Y., Wang, Y., Zhang, L., & Wang, Q. (2024). Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma. Advanced Science, 11(28). https://doi.org/10.1002/advs.202309084

Vancouver

Xie F, Qiu J, Sun C, Feng L, Jun Y, Luo C, et al. Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma. Advanced Science. 2024;11(28). doi:10.1002/advs.202309084

BibTeX
@article{Xie2024,
  author = {Xie, Fei and Qiu, Jinrong and Sun, Congyong and Feng, Lulu and Jun, Yali and Luo, Chao and Guo, Xiamei and Zhang, Bowei and Zhou, Yu and Wang, Yuting and Zhang, Li and Wang, Qilong},
  title = {Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {28},
  doi = {10.1002/advs.202309084}
}
Kostenlos starten →